Literature DB >> 6393703

Accumulation of IgG and complement factor C3 in human arterial endothelium and atherosclerotic lesions.

G K Hansson, J Holm, J G Kral.   

Abstract

Endothelial injury is associated with an intracellular accumulation of IgG. Fluorescent antibodies were used to detect IgG and complement factor C3 in biopsies of human arteries. Both proteins were found in endothelial cells with signs of injury, in normal and atherosclerotic arteries. Rhodamine-conjugated anti-IgG and FITC-conjugated anti-C3 were used to count the number of IgG- and C3-containing endothelial cells in non-atherosclerotic cystic arteries. IgG was found in 26% of the cells, with C3 in 38% of the IgG-containing cells. Both IgG and C3 were also observed in the subendothelial intima of cystic arteries and in atherosclerotic lesions of iliac and femoral arteries. The accumulation of IgG and C3 in injured endothelium and in atherosclerotic lesions could be of importance for complement-mediated tissue destruction and for the attraction and activation of white blood cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6393703     DOI: 10.1111/j.1699-0463.1984.tb04424.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  20 in total

1.  Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.

Authors:  Fengming Liu; Lin Wu; Gongxiong Wu; Chun Wang; Lining Zhang; Stephen Tomlinson; Xuebin Qin
Journal:  Atherosclerosis       Date:  2014-03-15       Impact factor: 5.162

2.  Menopause, complement, and hemostatic markers in women at midlife: the Study of Women's Health Across the Nation.

Authors:  Samar R El Khoudary; Kelly J Shields; Hsiang-Yu Chen; Karen A Matthews
Journal:  Atherosclerosis       Date:  2013-09-05       Impact factor: 5.162

3.  Immunoglobulin treatment reduces atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice via the complement system.

Authors:  L Persson; J Borén; A Nicoletti; G K Hansson; M Pekna
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries.

Authors:  C Guettier; N Hinglais; P Bruneval; M Kazatchkine; J Bariety; J P Camilleri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 5.  Immune and inflammatory mechanisms in the development of atherosclerosis.

Authors:  G K Hansson
Journal:  Br Heart J       Date:  1993-01

6.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans.

Authors:  A C van der Wal; P K Das; A J Tigges; A E Becker
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

8.  Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages.

Authors:  Denis A Mogilenko; Igor V Kudriavtsev; Andrey S Trulioff; Vladimir S Shavva; Ella B Dizhe; Boris V Missyul; Alexander V Zhakhov; Alexander M Ischenko; Andrej P Perevozchikov; Sergey V Orlov
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

9.  Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes.

Authors:  G A Ferns; M A Reidy; R Ross
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

10.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.